242 related articles for article (PubMed ID: 27248472)
1. AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway.
Huang C; Verhulst S; Shen Y; Bu Y; Cao Y; He Y; Wang Y; Huang D; Cai C; Rao K; Liao DF; Jin J; Cao D
Oncotarget; 2016 Jul; 7(28):43779-43791. PubMed ID: 27248472
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.
Baranwal S; Wang Y; Rathinam R; Lee J; Jin L; McGoey R; Pylayeva Y; Giancotti F; Blobe GC; Alahari SK
J Natl Cancer Inst; 2011 Oct; 103(20):1513-28. PubMed ID: 21917605
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
[TBL] [Abstract][Full Text] [Related]
4. Aldo-keto Reductase 1B10 Restrains Cell Migration, Invasion, and Adhesion of Gastric Cancer via Regulating Integrin Subunit Alpha 5.
Yao H; Hu J; Shao Y; Shah Q; Zheng S
Turk J Gastroenterol; 2023 Dec; 34(12):1197-1205. PubMed ID: 37823316
[TBL] [Abstract][Full Text] [Related]
5. AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling.
Li J; Guo Y; Duan L; Hu X; Zhang X; Hu J; Huang L; He R; Hu Z; Luo W; Tan T; Huang R; Liao D; Zhu YS; Luo DX
Oncotarget; 2017 May; 8(20):33694-33703. PubMed ID: 28402270
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.
Kim S; Kang HY; Nam EH; Choi MS; Zhao XF; Hong CS; Lee JW; Lee JH; Park YK
Carcinogenesis; 2010 Apr; 31(4):597-606. PubMed ID: 20118200
[TBL] [Abstract][Full Text] [Related]
7. The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.
Arpaia E; Blaser H; Quintela-Fandino M; Duncan G; Leong HS; Ablack A; Nambiar SC; Lind EF; Silvester J; Fleming CK; Rufini A; Tusche MW; Brüstle A; Ohashi PS; Lewis JD; Mak TW
Oncogene; 2012 Feb; 31(7):884-96. PubMed ID: 21765460
[TBL] [Abstract][Full Text] [Related]
8. AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells.
Huang C; Cao Z; Ma J; Shen Y; Bu Y; Khoshaba R; Shi G; Huang D; Liao DF; Ji H; Jin J; Cao D
Mol Carcinog; 2018 Oct; 57(10):1300-1310. PubMed ID: 29846015
[TBL] [Abstract][Full Text] [Related]
9. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
[TBL] [Abstract][Full Text] [Related]
10. HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42.
Johnson E; Seachrist DD; DeLeon-Rodriguez CM; Lozada KL; Miedler J; Abdul-Karim FW; Keri RA
J Biol Chem; 2010 Sep; 285(38):29491-501. PubMed ID: 20595387
[TBL] [Abstract][Full Text] [Related]
11. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
12. [AKR1B10 promotes proliferation of breast cancer cells by activating Wnt/β-catenin pathway].
Qu J; Liu X; Li J; Gong K; Duan L; Luo W; Luo D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Dec; 35(12):1094-1100. PubMed ID: 31894008
[TBL] [Abstract][Full Text] [Related]
13. Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis.
Wang Y; Shenouda S; Baranwal S; Rathinam R; Jain P; Bao L; Hazari S; Dash S; Alahari SK
Mol Cancer; 2011 Jul; 10():84. PubMed ID: 21752283
[TBL] [Abstract][Full Text] [Related]
14. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R
Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886
[TBL] [Abstract][Full Text] [Related]
15. AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.
Ma J; Luo DX; Huang C; Shen Y; Bu Y; Markwell S; Gao J; Liu J; Zu X; Cao Z; Gao Z; Lu F; Liao DF; Cao D
Int J Cancer; 2012 Sep; 131(6):E862-71. PubMed ID: 22539036
[TBL] [Abstract][Full Text] [Related]
16. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
17. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
[TBL] [Abstract][Full Text] [Related]
18. Cadmium stimulates metastasis-associated phenotype in triple-negative breast cancer cells through integrin and β-catenin signaling.
Wei Z; Shaikh ZA
Toxicol Appl Pharmacol; 2017 Aug; 328():70-80. PubMed ID: 28527916
[TBL] [Abstract][Full Text] [Related]
19. [Integrin α5 promotes the proliferation, invasion and adhesion of gastric cancer by regulating the FAK/Src/Rac1 signaling pathway].
Yao HB; Shao QS; Shao YF; Hu JF
Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2692-2697. PubMed ID: 34510875
[No Abstract] [Full Text] [Related]
20. KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.
Saha SK; Choi HY; Kim BW; Dayem AA; Yang GM; Kim KS; Yin YF; Cho SG
Oncogene; 2017 Jan; 36(3):332-349. PubMed ID: 27345400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]